Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic expanded CUG repeat RNAs are structured non-coding regions within certain transcripts that cause disease primarily through toxic gain-of-function at the RNA level. Their unique structure enables them to aberrantly interact with key cellular proteins leading to widespread dysregulation—most prominently seen in myotonic dystrophy type 1—and they represent an important target for therapeutic intervention using structure-specific molecules or nucleic acid-based drugs.
Disrupts protein sequestration; promotes selective degradation/cleavage of mutant transcripts; modifies RNA structure
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic Expanded CUG Repeat RNA (r(CUG)^exp).